We sought further confirmation of our hypothesis that vascular injury and TGF-β superfamily signaling combine to reactivate NKX2-5, using the TGFβR2 kinase–deficient model, which recapitulates key pathological features of systemic sclerosis (35–37). This evidence concerns the gene NKX2-5 and systemic sclerosis.